Atlas Trials

Study on Lixisenatide and Counterregulation to Hypoglycemia

Clinical trial NCT02020629 · COMPLETED

Trial details

NCT number
NCT02020629
Sponsor
Lund University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2013-12-01
Primary completion
2014-08-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.